Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR, p53, IDH-1 and MDM2 immunohistochemical analysis in glioblastoma: therapeutic and prognostic correlation.

Arquivos de neuro-psiquiatria - 1 Jul 2015

Montgomery Richard Murdoch, Queiroz Luciano de Souza, Rogerio Fabio

Abstract excerpt

We studied 36 glioblastoma cases at HC-UNICAMP from 2008 to 2012 and classified the immunohistochemical distribution of the wild-type epidermal growth factor receptor (EGFR), mutated forms of p53 protein and isocitrate dehydrogenase-1 (IDH-1) and murine double protein 2 (MDM2). Immunostaining fin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to ErbB Receptors
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Proto-Oncogene Proteins c-mdm2

Share to Reference Values

Share to Statistics, Nonparametric

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 26200049
DOI: 10.1590/0004-282X20150059

Genes

MDM2
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26200049-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR, p53, IDH-1 and MDM2 immunohistochemical analysis in glioblastoma: therapeutic and prognostic correlation.PMID 26200049Read ↗

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.Semantic proximity Read ↗

[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].Semantic proximity Read ↗

A practical review of prognostic correlations of molecular biomarkers in glioblastomaSemantic proximity Read ↗

Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.Semantic proximity Read ↗

[Clinical, immunohistochemical, and molecular genetic prognostic factors in adult patients with glioblastoma].Semantic proximity Read ↗

Immunohistochemical characterisation and histopathology of astrocytic neoplasms at a tertiary Nigerian hospital.Semantic proximity Read ↗

[Analysis of clinical, pathological features and therapeutic treatments in predicting prognosis of elderly glioblastomas].Semantic proximity Read ↗

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco.Semantic proximity Read ↗

Extracranial Metastasis of IDH-1 Wild Type Glioblastomas.Semantic proximity Read ↗

Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.Semantic proximity Read ↗

Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological featuresSemantic proximity Read ↗

Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.